Breaking News, Promotions & Moves

Vigene Biosciences Appoints COO

Molly McGlaughlin brings 27 years of experience in biologics manufacturing and development.

By: Contract Pharma

Contract Pharma Staff

Vigene Biosciences, an award-winning specialist in plasmid and viral vector development and manufacturing, has appointed Molly McGlaughlin as chief operation officer.    McGlaughlin, a long-term Biologics Contract Development and Manufacturing Organization (CDMO) industry senior executive, comes to us with 27 years of experiences in biologics manufacturing and development. She has served on the executive management teams of BioLexis, BioVectra, EirGenix, Selexis S.A., Natrix Separations, Cytovan...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters